Reduction by hyaluronidase of myocardial necrosis following coronary artery occlusion.
D000818:Animals; D001157:Arterial Occlusive Diseases / Q000188:drug therapy*; D003327:Coronary Disease / Q000188:drug therapy* / Q000201:enzymology / Q000473:pathology; D003402:Creatine Kinase / Q000032:analysis; D004285:Dogs; D004562:Electrocardiography; D006003:Glycogen / Q000032:analysis; D006821:Hyaluronoglucosaminidase / Q000627:therapeutic use*; D009203:Myocardial Infarction / Q000517:prevention & control; D009206:Myocardium / Q000032:analysis / Q000201:enzymology / Q000473:pathology; D009336:Necrosis; D013053:Spectrophotometry; D013997:Time Factors
D006003:Glycogen; D003402:Creatine Kinase; D006821:Hyaluronoglucosaminidase